Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis - Concepedia

Concepedia

Publication | Closed Access

Long-term results from a phase 2 extension study of fingolimod at high and approved dose in relapsing multiple sclerosis

22

Citations

12

References

2015

Year

Xavier Montalbán, Giancarlo Comi, Jack P. Antel, Paul O’Connor, Ana de Vera, Malika Cremer, Nikolaos Sfikas, Philipp von Rosenstiel, Ludwig Kappos

Journal of Neurology

Disease ProgressionNeurological DisorderClinical TrialsExtension StudyNeurologyMultiple SclerosisPhase 2MedicineNeuroimmunology

References

	Year	Citations

Page 1

Page 1